371 related articles for article (PubMed ID: 36040198)
1. Outer Membrane Vesicles of Actinobacillus pleuropneumoniae Exert Immunomodulatory Effects on Porcine Alveolar Macrophages.
Zhu Z; Antenucci F; Winther-Larsen HC; Skovgaard K; Bojesen AM
Microbiol Spectr; 2022 Oct; 10(5):e0181922. PubMed ID: 36040198
[TBL] [Abstract][Full Text] [Related]
2. In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.
Antenucci F; Fougeroux C; Deeney A; Ørskov C; Rycroft A; Holst PJ; Bojesen AM
Vet Res; 2018 Jan; 49(1):4. PubMed ID: 29316978
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.
Antenucci F; Fougeroux C; Bossé JT; Magnowska Z; Roesch C; Langford P; Holst PJ; Bojesen AM
Vet Res; 2017 Nov; 48(1):74. PubMed ID: 29122004
[TBL] [Abstract][Full Text] [Related]
4. Immunoproteomic characterization of outer membrane vesicles from hyper-vesiculating Actinobacillus pleuropneumoniae.
Antenucci F; Magnowska Z; Nimtz M; Roesch C; Jänsch L; Bojesen AM
Vet Microbiol; 2019 Aug; 235():188-194. PubMed ID: 31383301
[TBL] [Abstract][Full Text] [Related]
5. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
Loera-Muro A; Angulo C
Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
[TBL] [Abstract][Full Text] [Related]
6. Activation of Porcine Alveolar Macrophages by Actinobacillus pleuropneumoniae Lipopolysaccharide via the Toll-Like Receptor 4/NF-κB-Mediated Pathway.
Li B; Fang J; Zuo Z; Yin S; He T; Yang M; Deng J; Shen L; Ma X; Yu S; Wang Y; Ren Z
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229731
[No Abstract] [Full Text] [Related]
7. TurboID screening of ApxI toxin interactants identifies host proteins involved in Actinobacillus pleuropneumoniae-induced apoptosis of immortalized porcine alveolar macrophages.
Hu Y; Jiang C; Zhao Y; Cao H; Ren J; Zeng W; Zhang M; Li Y; He Q; Li W
Vet Res; 2023 Jul; 54(1):62. PubMed ID: 37475032
[TBL] [Abstract][Full Text] [Related]
8. Concurrent host-pathogen gene expression in the lungs of pigs challenged with Actinobacillus pleuropneumoniae.
Brogaard L; Klitgaard K; Heegaard PM; Hansen MS; Jensen TK; Skovgaard K
BMC Genomics; 2015 May; 16(1):417. PubMed ID: 26018580
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
[TBL] [Abstract][Full Text] [Related]
10. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
[TBL] [Abstract][Full Text] [Related]
11. malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid.
Lone AG; Deslandes V; Nash JH; Jacques M; MacInnes JI
BMC Microbiol; 2009 Sep; 9():195. PubMed ID: 19751522
[TBL] [Abstract][Full Text] [Related]
12. Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae.
Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Rodríguez-Ferri EF
Microbiologia; 1996 Jun; 12(2):171-84. PubMed ID: 8767702
[TBL] [Abstract][Full Text] [Related]
13. An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes--evaluation of isolates from lungs and tonsils of pigs.
Gram T; Ahrens P; Andreasen M; Nielsen JP
Vet Microbiol; 2000 Jul; 75(1):43-57. PubMed ID: 10865151
[TBL] [Abstract][Full Text] [Related]
14. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.
Xie F; Li G; Zhou L; Zhang Y; Cui N; Liu S; Wang C
BMC Vet Res; 2017 Jan; 13(1):14. PubMed ID: 28061786
[TBL] [Abstract][Full Text] [Related]
16. Native ApxIIA secreted by Actinobacillus pleuropneumoniae induces apoptosis in porcine alveolar macrophages dependent on concentration and acylation.
Tang H; Wang R; Pang S; Han W; Zhang Q; Fang Q; Chen X; Huang Q; Qiu D; Zhou R; Li L
Vet Microbiol; 2023 Dec; 287():109908. PubMed ID: 37952264
[TBL] [Abstract][Full Text] [Related]
17. A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
Xu K; Zhao Q; Wen X; Wu R; Wen Y; Huang X; Huang Y; Yan Q; Han X; Ma X; Chang YF; Cao S
PLoS One; 2018; 13(1):e0191286. PubMed ID: 29373591
[TBL] [Abstract][Full Text] [Related]
18. Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae.
Rycroft AN; Williams D; McCandlish IA; Taylor DJ
Vet Rec; 1991 Nov; 129(20):441-3. PubMed ID: 1781136
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional profiling of Actinobacillus pleuropneumoniae during the acute phase of a natural infection in pigs.
Deslandes V; Denicourt M; Girard C; Harel J; Nash JH; Jacques M
BMC Genomics; 2010 Feb; 11():98. PubMed ID: 20141640
[TBL] [Abstract][Full Text] [Related]
20. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
